{
  "module": "High_Alert_Medications_Pharm",
  "category": "High-Alert Medications & Patient Safety",
  "description": "Critical medications where errors cause significant harm: Insulin, Heparin, Warfarin, Opioids, Digoxin, Potassium, Magnesium. Focus on dosing safety, monitoring, and error prevention.",
  "generated_at_utc": "2025-12-10T00:00:00.000000Z",
  "total_questions": 30,
  "questions": [
    {
      "id": "HA_001",
      "stem": "A nurse is preparing to administer insulin lispro (Humalog) 10 units and NPH insulin 20 units subcutaneously. Which action is correct?",
      "options": [
        "Draw up the NPH insulin first, then the lispro",
        "Draw up the lispro first, then the NPH",
        "Mix both insulins in the same syringe after drawing up separately",
        "Administer in separate syringes at different sites"
      ],
      "correct": ["B"],
      "rationale": "When mixing rapid/short-acting insulin with intermediate-acting (NPH), always draw up the clear (rapid/short) insulin FIRST to prevent contamination. Mnemonic: 'Clear before Cloudy' or 'RN' (Regular/Rapid before NPH). This prevents NPH from contaminating the rapid-acting vial, which would alter onset times for future doses.",
      "type": "single_select"
    },
    {
      "id": "HA_002",
      "stem": "A patient's blood glucose is 58 mg/dL and they are conscious. What is the priority intervention?",
      "options": [
        "Administer 1 mg glucagon IM",
        "Give 15-20g fast-acting carbohydrate orally",
        "Start D50W IV bolus",
        "Give 4 oz orange juice and a turkey sandwich"
      ],
      "correct": ["B"],
      "rationale": "For conscious hypoglycemia, use the 15-15 rule: give 15g fast-acting carb (4oz juice, 3-4 glucose tablets, 1 Tbsp honey), wait 15 min, recheck. If still <70, repeat. Once normalized, give complex carb/protein to prevent rebound. Glucagon is for unconscious patients. D50W is for severe/unconscious hypoglycemia.",
      "type": "single_select"
    },
    {
      "id": "HA_003",
      "stem": "A nurse is preparing to administer IV insulin for DKA. The order reads '8 units/hr.' The pharmacy sends a bag labeled 'Regular insulin 100 units in 100 mL NS.' At what rate should the pump be set?",
      "options": [
        "8 mL/hr",
        "80 mL/hr",
        "0.8 mL/hr",
        "800 mL/hr"
      ],
      "correct": ["A"],
      "rationale": "Concentration is 1 unit/mL (100 units ÷ 100 mL). To give 8 units/hr, set pump at 8 mL/hr. Always use an infusion pump for IV insulin (high-alert medication). Double-check calculations with another nurse. Never abbreviate 'units' as 'U' (can be mistaken for '0').",
      "type": "single_select"
    },
    {
      "id": "HA_004",
      "stem": "A patient on a heparin drip has an aPTT of 110 seconds (control 30). What is the nurse's priority action?",
      "options": [
        "Continue current rate; this is therapeutic",
        "Decrease the infusion rate per protocol",
        "Stop the infusion and notify the provider",
        "Prepare to administer protamine sulfate"
      ],
      "correct": ["C"],
      "rationale": "Therapeutic aPTT is 1.5-2.5× control (45-75 sec). This patient's aPTT of 110 sec (>3× control) indicates excessive anticoagulation with serious bleeding risk. Stop the infusion immediately and notify provider. Monitor for bleeding. Protamine may be ordered if bleeding occurs (1mg protamine per 100 units heparin).",
      "type": "single_select"
    },
    {
      "id": "HA_005",
      "stem": "Before administering digoxin 0.25 mg PO, the nurse notes the patient's pulse is 54 bpm. What action is appropriate?",
      "options": [
        "Give the medication and document the pulse",
        "Hold the dose and notify the provider",
        "Give half the dose",
        "Recheck the pulse in 1 hour, then give"
      ],
      "correct": ["B"],
      "rationale": "Hold digoxin if pulse <60 bpm (adult) or <90-110 bpm (infant/child). Digoxin slows heart rate; giving it with bradycardia can cause dangerous rhythm disturbances. Also hold if signs of toxicity present (nausea, yellow-green halos, arrhythmias). Check digoxin level and potassium before notifying provider.",
      "type": "single_select"
    },
    {
      "id": "HA_006",
      "stem": "A patient receiving warfarin has an INR of 8.5 with no bleeding. What intervention does the nurse anticipate?",
      "options": [
        "Continue warfarin at current dose",
        "Hold warfarin and give oral vitamin K",
        "Give IV vitamin K and fresh frozen plasma",
        "Increase warfarin dose"
      ],
      "correct": ["B"],
      "rationale": "INR >5 without bleeding: hold warfarin, consider low-dose oral vitamin K (1-2.5mg). INR 5-9 with no bleeding typically requires holding doses until INR therapeutic. Vitamin K reverses warfarin but takes 12-24 hrs. For major bleeding or INR >10, give IV vitamin K + fresh frozen plasma or prothrombin complex concentrate.",
      "type": "single_select"
    },
    {
      "id": "HA_007",
      "stem": "A nurse is preparing to administer potassium chloride 40 mEq IV. Which action demonstrates safe practice?",
      "options": [
        "Administer undiluted via IV push over 2 minutes",
        "Dilute in 50 mL NS and infuse over 15 minutes",
        "Dilute in 100 mL NS and infuse via pump over 1 hour",
        "Add to 1 liter IV bag and infuse wide open"
      ],
      "correct": ["C"],
      "rationale": "IV potassium safety: NEVER give IV push (fatal dysrhythmias). Always dilute (max 40 mEq/L peripheral, 80 mEq/L central). Max rate 10 mEq/hr (20 mEq/hr with cardiac monitoring). Use infusion pump. Verify adequate urine output before giving. Concentrated K+ is very irritating to veins.",
      "type": "single_select"
    },
    {
      "id": "HA_008",
      "stem": "A patient on morphine PCA has a respiratory rate of 8/min and is minimally responsive. After stopping the PCA, what is the priority intervention?",
      "options": [
        "Administer naloxone per protocol",
        "Increase oxygen via nasal cannula",
        "Encourage deep breathing",
        "Notify the provider"
      ],
      "correct": ["A"],
      "rationale": "Respiratory rate <10/min with decreased LOC indicates opioid overdose requiring immediate naloxone. Give small doses (0.4mg) IV and titrate to effect (goal: adequate respirations, not full reversal which causes severe pain/withdrawal). Support airway/breathing. Notify provider. Patient may need repeated doses as naloxone has shorter half-life than most opioids.",
      "type": "single_select"
    },
    {
      "id": "HA_009",
      "stem": "A nurse receives an order: 'Regular insulin 10U subcut stat.' Which action ensures patient safety?",
      "options": [
        "Draw up 10 units and administer immediately",
        "Have another nurse verify the insulin type and dose before administration",
        "Draw up 100 units since 'U' means 100",
        "Clarify the order as 'U' is not an acceptable abbreviation"
      ],
      "correct": ["D"],
      "rationale": "NEVER use 'U' for units - it's on ISMP's dangerous abbreviations list (can be read as 0, causing 10-fold errors). Always write 'units' out fully. Also verify with another nurse per double-check protocol for insulin. Both actions (B and D) are needed, but clarifying the dangerous abbreviation is priority to prevent future errors.",
      "type": "single_select"
    },
    {
      "id": "HA_010",
      "stem": "A patient with Type 1 diabetes is NPO for surgery. Their morning insulin should be:",
      "options": [
        "Held completely until they can eat",
        "Given in full with IV D5W running",
        "Modified per provider orders (typically give basal, hold bolus)",
        "Given as usual with sips of juice"
      ],
      "correct": ["C"],
      "rationale": "NPO patients with Type 1 diabetes MUST have basal insulin (long-acting or insulin pump) to prevent DKA, even when not eating. Hold rapid-acting meal-time insulin. Maintain IV dextrose to prevent hypoglycemia. Frequent blood glucose monitoring. Never completely hold insulin in Type 1 diabetes (causes DKA).",
      "type": "single_select"
    },
    {
      "id": "HA_011",
      "stem": "Which insulin error represents the highest risk for patient harm?",
      "options": [
        "Giving rapid-acting insulin 20 minutes before a meal instead of 15 minutes",
        "Confusing insulin glargine (Lantus) with insulin lispro (Humalog)",
        "Drawing up NPH before regular insulin when mixing",
        "Administering insulin in the abdomen instead of the arm"
      ],
      "correct": ["B"],
      "rationale": "Confusing long-acting (glargine) with rapid-acting (lispro) is extremely dangerous: giving rapid-acting for basal needs causes severe hypoglycemia; giving long-acting as bolus doesn't cover meals, causing hyperglycemia and possible DKA. Sound-alike/look-alike insulin names are a major source of errors. Always verify insulin type with another nurse.",
      "type": "single_select"
    },
    {
      "id": "HA_012",
      "stem": "A postoperative patient on heparin prophylaxis (5000 units SC q12h) has a platelet count drop from 250,000 to 80,000/mm³. What condition should the nurse suspect?",
      "options": [
        "Normal response to heparin therapy",
        "Heparin-induced thrombocytopenia (HIT)",
        "Disseminated intravascular coagulation",
        "Idiopathic thrombocytopenic purpura"
      ],
      "correct": ["B"],
      "rationale": "Platelet drop >50% or to <150,000 within 5-10 days of heparin suggests HIT, a serious immune reaction causing arterial/venous thrombosis (not bleeding). Stop ALL heparin (including flushes). Start alternative anticoagulant (argatroban, fondaparinux). Never use heparin again. LMWH may also cause HIT but less commonly.",
      "type": "single_select"
    },
    {
      "id": "HA_013",
      "stem": "A nurse is preparing to administer magnesium sulfate 4g IV. The available solution is 20g/500mL. How many mL should be administered?",
      "options": [
        "100 mL",
        "200 mL",
        "50 mL",
        "25 mL"
      ],
      "correct": ["A"],
      "rationale": "Concentration: 20g/500mL = 0.04g/mL or 40mg/mL. For 4g: 4g ÷ 0.04g/mL = 100mL. Magnesium is high-alert: monitor deep tendon reflexes (first sign of toxicity is loss of reflexes), respiratory rate (>12/min), urine output (>30mL/hr). Keep calcium gluconate at bedside as antidote.",
      "type": "single_select"
    },
    {
      "id": "HA_014",
      "stem": "A patient taking both clopidogrel and aspirin reports black, tarry stools. What is the nurse's priority action?",
      "options": [
        "Continue medications and encourage iron-rich foods",
        "Hold both medications and notify provider immediately",
        "Hold the aspirin but continue clopidogrel",
        "Obtain stool sample for guaiac testing"
      ],
      "correct": ["B"],
      "rationale": "Black, tarry stools (melena) indicate GI bleeding. Dual antiplatelet therapy significantly increases bleeding risk. Stop both medications and notify provider STAT. Check hemoglobin/hematocrit, obtain IV access, monitor vital signs. May need endoscopy, transfusion, PPI therapy. While stool guaiac is appropriate, stopping the medications and notifying provider is more urgent.",
      "type": "single_select"
    },
    {
      "id": "HA_015",
      "stem": "Before administering enoxaparin (Lovenox) 1 mg/kg, the nurse discovers the patient weighs 110 kg. The dose would be 110 mg. What should the nurse do?",
      "options": [
        "Administer the calculated dose",
        "Question the order as it exceeds typical maximum dose",
        "Give half the dose",
        "Hold the medication"
      ],
      "correct": ["B"],
      "rationale": "LMWH doses typically don't exceed 150-180mg daily for treatment doses (prophylactic doses are fixed). Very high doses in obese patients increase bleeding risk. Verify order with provider - may need dose adjustment or consideration of unfractionated heparin with aPTT monitoring. Always question doses that seem unusual.",
      "type": "single_select"
    },
    {
      "id": "HA_016",
      "stem": "A patient is transitioning from IV heparin to warfarin. When should the heparin be discontinued?",
      "options": [
        "Immediately when warfarin is started",
        "When INR reaches 2.0-3.0 for 24 hours",
        "After 5 days of warfarin therapy",
        "When INR reaches 1.5"
      ],
      "correct": ["B"],
      "rationale": "Overlap heparin and warfarin for at least 5 days AND until INR is therapeutic (2.0-3.0) for 24 hours. Warfarin takes 2-5 days to reach therapeutic effect. Stopping heparin too early leaves patient unprotected. Warfarin initially decreases protein C (anticoagulant) before decreasing clotting factors, creating transient hypercoagulable state.",
      "type": "single_select"
    },
    {
      "id": "HA_017",
      "stem": "Which medication combination poses the highest risk for patient harm?",
      "options": [
        "Acetaminophen and ibuprofen",
        "Warfarin and aspirin",
        "Lisinopril and hydrochlorothiazide",
        "Metformin and glipizide"
      ],
      "correct": ["B"],
      "rationale": "Warfarin + aspirin dramatically increases bleeding risk (GI, intracranial). While sometimes used together under close supervision for specific indications (e.g., mechanical heart valves, acute coronary syndrome), this combination requires careful monitoring and carries high risk of serious hemorrhage. Other risky combinations: warfarin + NSAIDs, antiplatelet agents + anticoagulants.",
      "type": "single_select"
    },
    {
      "id": "HA_018",
      "stem": "A patient develops hyperkalemia (K+ 6.8 mEq/L) with peaked T-waves on ECG. Which medication provides the most rapid cardiac protection?",
      "options": [
        "Sodium polystyrene sulfonate (Kayexalate)",
        "Insulin and glucose IV",
        "Calcium gluconate IV",
        "Furosemide IV"
      ],
      "correct": ["C"],
      "rationale": "For severe hyperkalemia with ECG changes: (1) CALCIUM GLUCONATE first - immediately stabilizes cardiac membrane (doesn't lower K+, just protects heart), (2) Then INSULIN + GLUCOSE to shift K+ intracellularly (works in 15-30 min), (3) Kayexalate or dialysis to actually remove K+ (works in hours). Calcium is first-line for cardiac protection.",
      "type": "single_select"
    },
    {
      "id": "HA_019",
      "stem": "A nurse discovers a medication error: gave insulin glargine 15 units instead of insulin lispro 15 units before a meal. What is the priority action?",
      "options": [
        "Complete an incident report immediately",
        "Assess blood glucose and notify provider STAT",
        "Give the correct insulin (lispro) now",
        "Document the error in the chart"
      ],
      "correct": ["B"],
      "rationale": "Patient safety is priority. Assess current blood glucose and notify provider immediately. Glargine (long-acting) given as bolus won't cover the meal, causing hyperglycemia. The patient may need rapid-acting insulin now. Monitor closely for next 24 hours. After ensuring patient safety: complete incident report, document, implement prevention strategies. Never delay patient care to complete paperwork.",
      "type": "single_select"
    },
    {
      "id": "HA_020",
      "stem": "A patient on high-dose aspirin therapy (4g/day) for rheumatoid arthritis develops tinnitus and hearing loss. What is the nurse's interpretation?",
      "options": [
        "Expected side effect; continue medication",
        "Unrelated to aspirin; refer to ENT",
        "Sign of salicylate toxicity; hold dose and notify provider",
        "Allergic reaction; give epinephrine"
      ],
      "correct": ["C"],
      "rationale": "Tinnitus is the hallmark of salicylism (aspirin toxicity). Other signs: hearing loss, dizziness, headache, confusion, hyperventilation. Hold medication and notify provider. Check salicylate level. Toxicity can occur with chronic therapeutic dosing, not just overdose. Permanent hearing loss can occur if not recognized early.",
      "type": "single_select"
    }
  ]
}
